BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23279772)

  • 1. Pyoderma gangrenosum and high titer serum anti-CCP2 antibodies.
    Das SK; Banerjee N; Khaskil S; Mukherjee SS
    JNMA J Nepal Med Assoc; 2012; 52(185):36-9. PubMed ID: 23279772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
    Saracino A; Kelly R; Liew D; Chong A
    Australas J Dermatol; 2011 Aug; 52(3):218-21. PubMed ID: 21834821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum and ulcerative colitis in the tropics.
    Alese OB; Irabor DO
    Rev Soc Bras Med Trop; 2008; 41(6):664-7. PubMed ID: 19142449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital pyoderma gangrenosum: report of two cases and published work review of Japanese cases.
    Satoh M; Yamamoto T
    J Dermatol; 2013 Oct; 40(10):840-3. PubMed ID: 24033392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical negative pressure and skin transplantation for the treatment of pyoderma gangrenosum].
    Gámiz RC; Nielsen AM
    Ugeskr Laeger; 2011 Aug; 173(35):2132-3. PubMed ID: 21884666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works.
    Ohtsuka M; Yamamoto T
    J Dermatol; 2014 Aug; 41(8):732-5. PubMed ID: 24986043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
    Baglieri F; Scuderi G
    Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
    Kim DW; Lee BI; Park SH
    Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyoderma gangrenosum with aseptic spleen abscess].
    Brahimi N; Maubec E; Boccara O; Marinho E; Valeyrie-Allanore L; Lecaille C; Sebban V; Hersent B; Picard-Dahan C; Descamps V; Crickx B
    Ann Dermatol Venereol; 2009 Jan; 136(1):46-9. PubMed ID: 19171230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pyoderma gangrenosum with topical factor XIII.
    Hoetzenecker W; Guenova E; Mitev V; Schanz S; Ulmer A; Fierlbeck G
    Eur J Dermatol; 2013; 23(5):653-7. PubMed ID: 24135449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature.
    Androutsakos T; Stamopoulos P; Aroni K; Hatzis G
    BMC Gastroenterol; 2015 Oct; 15():149. PubMed ID: 26502871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pyoderma gangrenosum--clinical, laboratory and therapeutic approaches. Review of 28 cases].
    Duarte AF; Nogueira A; Lisboa C; Azevedo F
    Dermatol Online J; 2009 Jul; 15(7):3. PubMed ID: 19903431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum in a patient with essential thrombocythemia.
    King KW; Murray A
    J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyoderma gangrenosum associated with c-ANCA (h-lamp-2).
    Hoffman MD
    Int J Dermatol; 2001 Feb; 40(2):135-7. PubMed ID: 11328397
    [No Abstract]   [Full Text] [Related]  

  • 17. Case report: a case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes.
    Toyozawa S; Yamamoto Y; Nishide T; Kishioka A; Kanazawa N; Matsumoto Y; Kuroyanagi Y; Furukawa F
    Dermatol Online J; 2008 Nov; 14(11):17. PubMed ID: 19094855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma gangrenosum: a clinical manifestation of difficult diagnosis.
    Santos M; Talhari C; Rabelo RF; Schettini AP; Chirano CA; Talhari S
    An Bras Dermatol; 2011; 86(1):153-6. PubMed ID: 21437541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].
    Trémezaygues L; Schmaltz R; Vogt T; Reichrath J
    Hautarzt; 2010 Apr; 61(4):345-53; quiz 354-5. PubMed ID: 20361320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ; Gangaram HB; Hussein SH
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.